A detailed history of Oregon Public Employees Retirement Fund transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Oregon Public Employees Retirement Fund holds 22,083 shares of VRTX stock, worth $10.4 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
22,083
Previous 22,173 0.41%
Holding current value
$10.4 Million
Previous $10.4 Million 1.17%
% of portfolio
0.2%
Previous 0.22%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$460.0 - $505.78 $41,400 - $45,520
-90 Reduced 0.41%
22,083 $10.3 Million
Q2 2024

Aug 01, 2024

BUY
$392.81 - $485.53 $39,281 - $48,553
100 Added 0.45%
22,173 $10.4 Million
Q1 2024

May 02, 2024

SELL
$407.69 - $446.08 $6.28 Million - $6.88 Million
-15,415 Reduced 41.12%
22,073 $9.23 Million
Q4 2023

Feb 12, 2024

SELL
$343.0 - $410.68 $4.31 Million - $5.16 Million
-12,556 Reduced 25.09%
37,488 $15.3 Million
Q3 2023

Oct 26, 2023

SELL
$338.18 - $362.46 $4.88 Million - $5.23 Million
-14,436 Reduced 22.39%
50,044 $17.4 Million
Q2 2023

Jul 26, 2023

SELL
$314.42 - $351.91 $9.46 Million - $10.6 Million
-30,087 Reduced 31.82%
64,480 $22.7 Million
Q1 2023

May 04, 2023

SELL
$283.23 - $323.1 $78,737 - $89,821
-278 Reduced 0.29%
94,567 $29.8 Million
Q4 2022

Jan 26, 2023

BUY
$285.76 - $321.48 $4.16 Million - $4.68 Million
14,571 Added 18.15%
94,845 $0
Q3 2022

Nov 01, 2022

SELL
$273.83 - $305.53 $1.02 Million - $1.14 Million
-3,742 Reduced 4.45%
80,274 $23.2 Million
Q2 2022

Jul 25, 2022

BUY
$234.96 - $292.55 $14.9 Million - $18.6 Million
63,550 Added 310.52%
84,016 $23.7 Million
Q1 2022

Apr 21, 2022

SELL
$221.42 - $260.97 $127,095 - $149,796
-574 Reduced 2.73%
20,466 $5.34 Million
Q4 2021

Feb 01, 2022

SELL
$177.01 - $223.45 $107,799 - $136,081
-609 Reduced 2.81%
21,040 $4.62 Million
Q3 2021

Oct 19, 2021

SELL
$181.39 - $202.99 $53,691 - $60,085
-296 Reduced 1.35%
21,649 $3.93 Million
Q2 2021

Jul 23, 2021

SELL
$187.49 - $221.1 $498,910 - $588,347
-2,661 Reduced 10.81%
21,945 $4.43 Million
Q1 2021

Apr 20, 2021

SELL
$207.02 - $241.31 $24,635 - $28,715
-119 Reduced 0.48%
24,606 $5.29 Million
Q4 2020

Feb 09, 2021

SELL
$207.01 - $276.09 $8.33 Million - $11.1 Million
-40,254 Reduced 61.95%
24,725 $5.84 Million
Q3 2020

Nov 03, 2020

SELL
$255.65 - $303.1 $1.16 Million - $1.37 Million
-4,529 Reduced 6.52%
64,979 $17.7 Million
Q2 2020

Jul 21, 2020

SELL
$225.48 - $295.8 $2.25 Million - $2.95 Million
-9,969 Reduced 12.54%
69,508 $20.2 Million
Q1 2020

Apr 20, 2020

BUY
$199.77 - $247.81 $11 Million - $13.6 Million
55,018 Added 224.94%
79,477 $18.9 Million
Q4 2019

Feb 05, 2020

SELL
$166.71 - $223.91 $237,561 - $319,071
-1,425 Reduced 5.51%
24,459 $5.36 Million
Q3 2019

Nov 07, 2019

SELL
$166.23 - $187.09 $210,613 - $237,043
-1,267 Reduced 4.67%
25,884 $4.39 Million
Q2 2019

Jul 16, 2019

BUY
$164.61 - $190.37 $26,172 - $30,268
159 Added 0.59%
27,151 $4.98 Million
Q1 2019

May 07, 2019

SELL
$163.73 - $194.7 $136,387 - $162,185
-833 Reduced 2.99%
26,992 $4.97 Million
Q4 2018

Feb 07, 2019

SELL
$151.91 - $192.21 $696 Million - $881 Million
-4,583,056 Reduced 99.4%
27,825 $4.61 Million
Q4 2018

Feb 05, 2019

BUY
$151.91 - $192.21 $696 Million - $881 Million
4,583,156 Added 16530.77%
4,610,881 $28,000
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $165,537 - $193,074
1,136 Added 4.27%
27,725 $4.71 Million
Q1 2018

Apr 12, 2018

BUY
$151.6 - $177.13 $8,034 - $9,387
53 Added 0.2%
26,589 $4.33 Million
Q3 2017

Nov 02, 2017

BUY
$148.13 - $162.24 $3.93 Million - $4.31 Million
26,536
26,536 $4.04 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Oregon Public Employees Retirement Fund Portfolio

Follow Oregon Public Employees Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.